Tuesday, September 1, 2015 Last update: 12:33 AM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

Regulus Therapeutics Inc.

News articles for Regulus Therapeutics Inc.:

Tuesday, August 25, 2015

  • Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
    LA JOLLA, Calif., Aug. 25, 2015 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the appointment of Michael Huang, M.D. as Vice President, Clinical Development. Dr. Huang is an experienced drug developer with proven ... read more

Thursday, August 6, 2015

  • Regulus to Present at the 2015 Wedbush PacGrow Healthcare Conference
    LA JOLLA, Calif., Aug. 6, 2015 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that Paul Grint, M.D., President and CEO of Regulus, will present a company overview at the 2015 Wedbush PacGrow Healthcare ... read more

Tuesday, August 4, 2015

  • Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights
    LA JOLLA, Calif., Aug. 4, 2015 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported financial results and highlights for the quarter ended June 30, 2015 and provided a summary of recent corporate highlights. http://photos.prnewswire.com/prnvar/20150130/172637LOGO "The second quarter of 2015 ... read more

Tuesday, July 28, 2015

Thursday, June 4, 2015

Monday, June 1, 2015

Thursday, May 7, 2015

  • Regulus Reports First Quarter 2015 Financial Results and Recent Highlights
    LA JOLLA, Calif., May 7, 2015 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported financial results for the first quarter ended March 31, 2015, including a summary of recent corporate highlights. http://photos.prnewswire.com/prnvar/20150130/172637LOGO "The highlights during the first quarter and ... read more

Thursday, April 30, 2015

Wednesday, April 29, 2015

  • Regulus to Present at the Deutsche Bank 40th Annual Healthcare Conference
    LA JOLLA, Calif., April 29, 2015 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that Paul Grint, M.D., Chief Medical Officer of Regulus, will present a company overview at the Deutsche Bank 40(th) Annual ... read more

Saturday, April 25, 2015

Tuesday, April 7, 2015

Wednesday, March 25, 2015